advanced search

INJECTION

FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS
WEARABLES
Peter Schmidt
ZwickRoell
FROM PRECISION TO PERFECTION: NEW ON-BODY DELIVERY SYSTEM TESTING SOLUTIONS
Peter Schmidt details the advantages ZwickRoell’s integrated testing systems offer for ensuring precise and accurate testing of on-body drug delivery systems, including the prevention of static charge and the company’s advanced camera-based measurement systems.
ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY
WEARABLES
Omar Rahman
Enable Injections
ENHANCING THE PATIENT AND NURSE EXPERIENCE IN LARGE-VOLUME SUBCUTANEOUS DRUG DELIVERY
Omar Rahman, Beth Faiman and Lisa Gorski highlight the importance of a comfortable experience for both patients and healthcare providers when it comes to large-volume subcutaneous drug delivery.
TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS
WEARABLES
Dr Andrea Allmendinger
ten23 health
TECHNICAL CHALLENGES DURING THE DEVELOPMENT OF ON-BODY INJECTORS
Andrea Allmendinger, Michael Adler, Carole Delauney and Hanns-Christian Mahler provide an overview of large-volume wearable injection devices for the subcutaneous delivery of biologics and discuss the technical challenges associated with the development and manufacturing of these drug/device combination products.
DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE
EARLY INSIGHT
Dr Chaoyoung Lee
TxSphere
DESIGNING A MORE VERSATILE AND MODERN WEARABLE DEVICE
Chaoyoung Lee and Mike Stout introduce the Horizon wearable micro-pump platform, a cutting-edge advancement in the drug delivery device market that marks a significant contribution to wearable drug-device design.
THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS
EXPERT VIEW
Dave Beckstoffer
THE SPECIFIC APPROACH: THE ADVANTAGE OF CUSTOMISATION FOR WEARABLE DELIVERY SYSTEMS
Dave Beckstoffer considers how involving customisation from the outset of an on-body injector development project can not only optimise the patient outcome but also streamline the development timescale for device engineers, with a particular focus on the drive system.
FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN
INDUSTRIALISATION
Lorenzo Vaccarella
Paragon Medical
FUTURE-PROOFING YOUR DRUG DELIVERY DEVICE: CONSIDERATIONS FOR EFFECTIVE DESIGN
Lorenzo Vaccarella highlights six critical areas to consider early in the drug delivery device development journey. He discusses how strategically investing time during the early stages of the design cycle and throughout development can ultimately save both time and cost down the road when the product is being manufactured and deployed into the market.
DELIVERING INTELLIGENT AUTOINJECTOR ASSEMBLY SOLUTIONS FOR COMPLEX CUSTOMER-SPECIFIC REQUIREMENTS
INDUSTRIALISATION
Lars Keinicke Hansen
Stevanato Group
DELIVERING INTELLIGENT AUTOINJECTOR ASSEMBLY SOLUTIONS FOR COMPLEX CUSTOMER-SPECIFIC REQUIREMENTS
Lars Keinicke Hansen discusses the potential of technology to enhance the efficiency and productivity of manufacturing processes for both pharmaceutical companies and contract development and manufacturing organisations, as well as the skills and expertise required to maximise the potential gains technology can offer.
FROM IDEA TO MASS PRODUCTION: RAPIDLY AND SAFELY INDUSTRIALISING INNOVATIONS
INDUSTRIALISATION
Michael Wiglenda
Gerresheimer
FROM IDEA TO MASS PRODUCTION: RAPIDLY AND SAFELY INDUSTRIALISING INNOVATIONS
Michael Wiglenda describes Gerresheimer’s approach to the industrialisation of drug delivery devices, using the production of the company’s Gx Inbeneo® cartridge-based autoinjector as an example.
AUTOMATING HIGH-MIX, LOW-TO-MEDIUM-VOLUME AUTOINJECTOR ASSEMBLY
INDUSTRIALISATION
Colby Chen
SHL Medical
AUTOMATING HIGH-MIX, LOW-TO-MEDIUM-VOLUME AUTOINJECTOR ASSEMBLY
Colby Chen and Ian Chang discuss how the introduction of modularity can close the gap in traditional assembly systems to enable fully automated, high-quality autoinjector assembly in support of low- volume/high-mix manufacturing.
YPSOMED’S PLATFORM PRODUCT TRANSFORMATION AND APPROACH TO STRATEGIC PARTNER NETWORKING FOR SELF-INJECTION DEVICES
INDUSTRIALISATION
Ian Thompson
Ypsomed
YPSOMED’S PLATFORM PRODUCT TRANSFORMATION AND APPROACH TO STRATEGIC PARTNER NETWORKING FOR SELF-INJECTION DEVICES
Ian Thompson describes how Ypsomed has transformed the market for platform-based self-injection devices and extended the concept of platform products beyond the core device by developing working practices with strategic networking partners, helping pharma companies and patients to source safe, reliable and easy-to-use drug-device combination products.
MACHINABILITY OF ETFE-FILM-COATED PREFILLED SYRINGE PLUNGER WITH VENT-TUBE INSERTION
INDUSTRIALISATION
Sebastien Cordier
Aptar Pharma
MACHINABILITY OF ETFE-FILM-COATED PREFILLED SYRINGE PLUNGER WITH VENT-TUBE INSERTION
Sebastien Cordier, Benjamin Brocco, Audrey Chardonnet and Edgar Bauer discuss the results of tests on the performance of PremiumCoat® syringe plungers on high-speed fill-finish operations with vented insertion.
MATERIAL SELECTION & EFFICIENT DEVELOPMENT PROCESSES FOR WEARABLE INJECTOR DRIVE SYSTEMS
EXPERT VIEW
Dave Beckstoffer
MATERIAL SELECTION & EFFICIENT DEVELOPMENT PROCESSES FOR WEARABLE INJECTOR DRIVE SYSTEMS
Dave Beckstoffer explains the importance of material selection in drive system development, the key attributes of materials towards a wearable and auto-delivery device, and discusses the need to achieve industrialisation based on material selection and relevant manufacturing processes.
SMART MEMS CAP FOR SHARPS WASTE: A SIMPLE AND ELEGANT SOLUTION TO CLINICAL TRIAL ADHERENCE MONITORING
CONNECTIVITY
Frank Leipold
Haselmeier
SMART MEMS CAP FOR SHARPS WASTE: A SIMPLE AND ELEGANT SOLUTION TO CLINICAL TRIAL ADHERENCE MONITORING
Frank Leipold and Bernard Vrijens discuss Haselmeier & AARDEX’ s collaboration to develop the MEMS Smart Cap – a smart solution for data collection during clinical trials to enable an accurate assessment of participant nonadherence.
DIGITAL SELF-CARE – SOLVING PATIENT CHALLENGES WHILE DELIVERING BUSINESS INSIGHTS TO PHARMA
CONNECTIVITY
Dr Stefanie Seiler
Ypsomed
DIGITAL SELF-CARE – SOLVING PATIENT CHALLENGES WHILE DELIVERING BUSINESS INSIGHTS TO PHARMA
Stefanie Seiler and Ventsislav Dobrev discuss self-care challenges for patients and highlight how Ypsomed Digital Health’s solutions can solve them while also delivering meaningful business insights for pharmaceutical companies. 
Interview with DEAN MINNOCK
INTERVIEW
Dr Dean Minnock
Innovation Zed
Interview with DEAN MINNOCK
Guy Furness and Dean Minnock discuss Innovation Zed’s unique origin story and digital connectivity add-on for injection pens. They dive into the value of digital ecosystems in the drug delivery industry and look towards the future as the company prepares to launch its third-generation add-on technology – DOSE.
BRINGING DIGITAL HEALTH AND DRUG DELIVERY TOGETHER TO SUPPORT SUBCUTANEOUS INJECTION IN ONCOLOGY
CONNECTIVITY
Damien McKeon
Aptar Digital Health
BRINGING DIGITAL HEALTH AND DRUG DELIVERY TOGETHER TO SUPPORT SUBCUTANEOUS INJECTION IN ONCOLOGY
Damien McKeon and Sueyoung Yoon discuss the trends driving interest in subcutaneous administration, the barriers to overcome and the characteristics of a patient-centric solution.
Interview with Eric Leven, Rip Road
INTERVIEW
Eric Leven
Rip Road
Interview with Eric Leven, Rip Road
Guy Furness and Eric Leven discuss Rip Road’s work with SaMD applications, including the company's customisable platform for delivery device companion apps. Leven shares his thoughts on the potential of connectivity to enhance the patient experience of biologic therapies, based on years working in the digital space, as well as how far connected drug delivery has come and how far it has yet to go.
CHALLENGES IN TESTING THE ACCURACY OF INFUSION PUMP DOSES
INJECTION
Lucas Foerster
Sartorius
CHALLENGES IN TESTING THE ACCURACY OF INFUSION PUMP DOSES
Lucas Foerster and Dieter Peissig explore the critical factors in choosing the right balance for infusion pump performance validation and discuss potential sources of error.
SHL MOLLY<sup>®</sup> AUTOINJECTORS: POWERING THE NEXT WAVE OF CARDIOMETABOLIC CARE
INJECTION
Lars Berger
SHL Medical
SHL MOLLY® AUTOINJECTORS: POWERING THE NEXT WAVE OF CARDIOMETABOLIC CARE
Lars Berger and Eric Linvill discuss the rapid growth of the cardiometabolic disease space in light of the global obesity epidemic and how advanced autoinjector and injection pen technologies, such as SHL Medical’s Molly platform, will be necessary to meet the challenges presented by this disease area.
PACKAGING MATERIAL IDENTIFICATION TO ENSURE SELECTION OF BEST-MATCHING COMPONENTS FOR PARENTERAL DRUGS
INJECTION
Dr Uwe Rothhaar
SCHOTT Pharma
PACKAGING MATERIAL IDENTIFICATION TO ENSURE SELECTION OF BEST-MATCHING COMPONENTS FOR PARENTERAL DRUGS
Uwe Rothhaar, Daniel Haines, Matthias Bicker and Thomas Schmidt discuss the analytical techniques used to identify the material components and composition of primary containers for injectable drug products.
VIAL STOPPER COMPATIBILITY: CRITERIA AND TESTING METHODS FOR PHARMACEUTICAL PACKAGING
INJECTION
Dr Laure-Helene Guillemot
Aptar Pharma
VIAL STOPPER COMPATIBILITY: CRITERIA AND TESTING METHODS FOR PHARMACEUTICAL PACKAGING
Laure-Hélène Guillemot, Benjamin Brocco, Edouard Pagnoud and Pascal Sircoulomb, discuss some of the key parameters to consider when choosing a vial stopper and present evaluation methods that were developed to test and demonstrate the compatibility of various stoppers with commonly used vial designs.
OXYCAPT VIAL’S CONTAINER CLOSURE INTEGRITY AT -80°C WITH DRY ICE AND CO<sub>2</sub> BARRIER
INJECTION
Masashi Miura
Mitsubishi Gas Chemical
OXYCAPT VIAL’S CONTAINER CLOSURE INTEGRITY AT -80°C WITH DRY ICE AND CO2 BARRIER
Masashi Miura and Tomohiro Suzuki, discuss the beneficial features of the OXYCAPT™ multilayer vial for biologics and gene and cell therapies, sharing recent study results highlighting OXYCAPT’s performance at -80°C under dry-ice conditions and its high carbon dioxide barrier compared with standard cyclo-olefin polymer.
THE CHALLENGES OF DEVELOPING DRUG DELIVERY DEVICES FOR THE JAPANESE MARKET
INJECTION
Olivia Houselander
Owen Mumford
THE CHALLENGES OF DEVELOPING DRUG DELIVERY DEVICES FOR THE JAPANESE MARKET
Olivia Houselander outlines some of the challenges of developing drug delivery devices for the Japanese market and shares details of Owen Mumford’s latest two products to gain approval in Japan.
NAVIGATING THE TRANSITION FROM MDD TO MDR FOR CO-PACKAGED COMBINATION PRODUCTS
INJECTION
Paul Scannell
West Pharmaceutical Services
NAVIGATING THE TRANSITION FROM MDD TO MDR FOR CO-PACKAGED COMBINATION PRODUCTS
Paul Scannell explains how to safely navigate the regulatory landscape for co-packaged drug-device combination products.
Top